Riboflavin 5'-Phosphate
ApprovedCompleted 2 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Keratoconus
Conditions
Keratoconus, Keratoconus, Unstable
Trial Timeline
Jul 18, 2017 → Sep 30, 2019
NCT ID
NCT03245853About Riboflavin 5'-Phosphate
Riboflavin 5'-Phosphate is a approved stage product being developed by Glaukos for Keratoconus. The current trial status is completed. This product is registered under clinical trial identifier NCT03245853. Target conditions include Keratoconus, Keratoconus, Unstable.
What happened to similar drugs?
1 of 6 similar drugs in Keratoconus were approved
Approved (1) Terminated (1) Active (4)
Hype Score Breakdown
Clinical
20
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03245853 | Approved | Completed |
Competing Products
7 competing products in Keratoconus
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| riboflavin solution + placebo solution | Glaukos | Phase 3 | 37 |
| riboflavin ophthalmic solution | Glaukos | Phase 3 | 37 |
| GLK-221 Ophthalmic Solution + Placebo Ophthalmic Solution | Glaukos | Phase 2 | 39 |
| riboflavin solution + placebo solution | Glaukos | Phase 3 | 29 |
| riboflavin solution + placebo solution | Glaukos | Phase 3 | 37 |
| Test Article A + Test Article B + Placebo | Glaukos | Phase 3 | 37 |
| Dextenza + Prednisolone Acetate | Ocular Therapeutix | Approved | 37 |